LifeVantage (NASDAQ:LFVN) Stock Crosses Above Two Hundred Day Moving Average - What's Next?

LifeVantage Co. (NASDAQ:LFVN - Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $8.77 and traded as high as $14.18. LifeVantage shares last traded at $13.74, with a volume of 109,493 shares traded.

LifeVantage Trading Up 3.3 %

The stock's 50-day moving average price is $11.81 and its 200-day moving average price is $8.82. The stock has a market cap of $177.66 million, a price-to-earnings ratio of 44.35 and a beta of 0.84.

LifeVantage (NASDAQ:LFVN - Get Free Report) last issued its quarterly earnings results on Tuesday, October 29th. The company reported $0.15 EPS for the quarter, meeting analysts' consensus estimates of $0.15. LifeVantage had a net margin of 2.11% and a return on equity of 29.24%. The business had revenue of $47.21 million for the quarter.

LifeVantage Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Monday, December 2nd will be issued a $0.04 dividend. The ex-dividend date of this dividend is Monday, December 2nd. This represents a $0.16 dividend on an annualized basis and a yield of 1.13%. LifeVantage's payout ratio is currently 50.00%.

Institutional Trading of LifeVantage

Several large investors have recently modified their holdings of the stock. Capital Management Corp VA bought a new position in LifeVantage during the third quarter worth $5,073,000. Vanguard Group Inc. raised its stake in LifeVantage by 2.8% during the 1st quarter. Vanguard Group Inc. now owns 475,021 shares of the company's stock worth $2,874,000 after buying an additional 12,809 shares during the period. Renaissance Technologies LLC raised its stake in LifeVantage by 2.1% during the 2nd quarter. Renaissance Technologies LLC now owns 855,118 shares of the company's stock worth $5,490,000 after buying an additional 17,300 shares during the period. Empowered Funds LLC grew its stake in LifeVantage by 8.1% in the first quarter. Empowered Funds LLC now owns 76,203 shares of the company's stock valued at $461,000 after acquiring an additional 5,742 shares during the period. Finally, Ritholtz Wealth Management increased its holdings in shares of LifeVantage by 62.0% during the third quarter. Ritholtz Wealth Management now owns 28,666 shares of the company's stock valued at $346,000 after acquiring an additional 10,974 shares in the last quarter. Institutional investors and hedge funds own 35.32% of the company's stock.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.